Insights Into the European Market for Bio-Based Chemicals

Total Page:16

File Type:pdf, Size:1020Kb

Insights Into the European Market for Bio-Based Chemicals Insights into the European market for bio-based chemicals Analysis based on 10 key product categories Jurjen Spekreijse Tijs Lammens Claudia Parisi Tévécia Ronzon Martijn Vis 2019 EUR 29581 EN This publication is a Science for Policy report by the Joint Research Centre (JRC), the European Commission’s science and knowledge service. It aims to provide evidence-based scientific support to the European policymaking process. The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication. Contact information Name: Claudia Parisi Address: Edificio EXPO, c/ Inca Garcilaso, 3, E-41092 Seville (Spain) Email: [email protected] JRC Science Hub https://ec.europa.eu/jrc JRC112989 EUR 29581 EN Print ISBN 978-92-79-98419-8 ISSN 1018-5593 doi:10.2760/673071 PDF ISBN 978-92-79-98420-4 ISSN 1831-9424 doi:10.2760/549564 Luxembourg: Publications Office of the European Union, 2019 © European Union, 2019 Reuse is authorised provided the source is acknowledged. The reuse policy of European Commission documents is regulated by Decision 2011/833/EU (OJ L 330, 14.12.2011, p. 39). For any use or reproduction of photos or other material that is not under the EU copyright, permission must be sought directly from the copyright holders. How to cite this report: Spekreijse, J., Lammens, T., Parisi, C., Ronzon, T., Vis, M., Insights into the European market of bio-based chemicals. Analysis based on ten key product categories, EUR 29581 EN, Publications Office of the European Union, Luxembourg, 2019, ISBN 978-92-79-98420-4, doi:10.2760/549564, JRC112989. All images © European Union 2019, except images on the cover page: 2017. Yemelyanov., M.- © Adobe Stock, 2015. Bits and Splits - © Adobe Stock, 2013. t4nkyong - © Adobe Stock, 2018. ddukang - © Adobe Stock Title Insights into the European market of bio-based chemicals Abstract Bio-based products can bring new functionalities to the market and make the EU economy more sustainable. According to this analysis, based on ten key chemical categories, the EU produces 4.7 Mt/a of bio-based chemicals which represents a bio-based share of about 3.0%, although the market is diverse and large differences can be found between product categories. Under a business-as-usual scenario, the overall bio-based share of the market is not expected to increase rapidly, with an estimated CAGR of 3.6%. Hurdles are still present in the development of the bio-based industry (e.g. production costs), but also big opportunities have been identified and new policy measures could help. Contents Acknowledgements ................................................................................................ 3 Executive summary ............................................................................................... 4 1 Introduction .................................................................................................... 12 1.1 Background of the study ............................................................................. 12 1.2 Objectives ................................................................................................ 12 1.3 Scope and limitations of the study ............................................................... 13 1.4 This report ................................................................................................ 14 2 Methodology ................................................................................................... 15 2.1 Identification and selection of bio-based product categories ............................ 15 2.2 Characterisation of the longlist of bio-based products ..................................... 16 2.3 Selection of 20 bio-based products for value chain description......................... 18 2.4 Selection of 50 representative bio-based products for market description ......... 19 2.5 Methodology for market data collection on 50 bio-based products .................... 23 2.5.1 Market data uncertainty indicator......................................................... 23 2.5.2 Statistical data .................................................................................. 24 2.5.3 Other market data ............................................................................. 27 2.6 Method for market data collection at product category level ............................ 27 2.7 Analysis of data quality and gaps ................................................................. 28 3 Results ........................................................................................................... 29 3.1 Value chain description ............................................................................... 29 3.2 Production and bio-based share ................................................................... 30 3.2.1 Production and bio-based share of 50 bio-based products ....................... 30 3.2.2 Production and bio-based share at product category level ....................... 36 3.3 Price and turnover ..................................................................................... 41 3.3.1 The prices of the 50 bio-based products ............................................... 41 3.3.2 Turnover figures for the 50 bio-based products...................................... 45 3.3.3 Price and turnover data for the 10 bio-based product categories .............. 46 3.4 The EU’s consumption and trade .................................................................. 47 3.4.1 Data on consumption and net trade for 50 bio-based products ................ 47 3.4.2 Consumption and EU import dependence at product category level .......... 53 3.5 Feedstock use, feedstock import dependence and land use ............................. 55 3.5.1 Feedstock use of the 50 bio-based products .......................................... 55 3.5.2 Land requirement of the 50 bio-based products ..................................... 58 3.5.3 Feedstock use, import dependence and land use at product category level 61 3.6 Future market size ..................................................................................... 64 3.7 Private investments ................................................................................... 67 i 3.8 Importance of Member States and the EU ..................................................... 68 3.8.1 Importance of Member States ............................................................. 68 3.8.2 Importance of the EU ......................................................................... 69 3.9 Maturity level ............................................................................................ 71 3.10 SWOT analysis on future development potential ...................................... 72 4 Conclusions and recommendations .................................................................... 81 4.1 Conclusions ............................................................................................... 81 4.2 Recommendations ..................................................................................... 84 List of abbreviations and definitions ....................................................................... 94 List of figures ...................................................................................................... 96 List of tables ....................................................................................................... 97 Annexes ............................................................................................................. 99 ii Acknowledgements This publication is part of the contribution of the Joint Research Centre (JRC) to the European Commission’s Knowledge Centre for Bioeconomy. The research was funded by an administrative arrangement between the Directorate-General for Research and Innovation (DG RTD) and the JRC. The authors would like to thank the other members of the bioeconomy team at JRC Seville (Robert M’barek, George Philippidis and Patricia Gurría) for reviewing the document and providing useful input; Maria Fernandez Gutierrez and Garbiñe Guiu of DG RTD for their help in defining the scope of the study and their useful feedback; and, finally, Marios Avraamides and Elena Garbarino for the final review of the document. Authors Jurjen Spekreijse Tijs Lammens Claudia Parisi Tévécia Ronzon Martijn Vis 3 Executive summary Background Europe’s economy depends on oil and gas for the chemicals and energy sectors and for all kinds of everyday products. However, fossil resources are scarce and their use harms the environment and our climate. Bio-based products can be substituted for fossil-based materials and bring new functionalities to the market, making the economy more sustainable and reducing its dependence on fossil resources. Industry, supported by governments and large research programmes such as Horizon 2020, has developed an array of innovative bio-based products, which are expected to find their way onto the market in increasing numbers. However, monitoring the development of the bio-based economy is challenging, since no official European databases are dedicated to bio-based products for industrial use, such as bio-based chemical products. Scope and goal This study aims to provide a detailed description of a segment of the EU bio-based products sector, represented by 10 chemical product categories, and its application markets: . platform chemicals . solvents . polymers
Recommended publications
  • Altered Metabolome of Lipids and Amino Acids Species: a Source of Early Signature Biomarkers of T2DM
    Journal of Clinical Medicine Review Altered Metabolome of Lipids and Amino Acids Species: A Source of Early Signature Biomarkers of T2DM Ahsan Hameed 1 , Patrycja Mojsak 1, Angelika Buczynska 2 , Hafiz Ansar Rasul Suleria 3 , Adam Kretowski 1,2 and Michal Ciborowski 1,* 1 Clinical Research Center, Medical University of Bialystok, Jana Kili´nskiegoStreet 1, 15-089 Bialystok, Poland; [email protected] (A.H.); [email protected] (P.M.); [email protected] (A.K.) 2 Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland; [email protected] 3 School of Agriculture and Food System, The University of Melbourne, Parkville, VIC 3010, Australia; hafi[email protected] * Correspondence: [email protected] Received: 27 June 2020; Accepted: 14 July 2020; Published: 16 July 2020 Abstract: Diabetes mellitus, a disease of modern civilization, is considered the major mainstay of mortalities around the globe. A great number of biochemical changes have been proposed to occur at metabolic levels between perturbed glucose, amino acid, and lipid metabolism to finally diagnoe diabetes mellitus. This window period, which varies from person to person, provides us with a unique opportunity for early detection, delaying, deferral and even prevention of diabetes. The early detection of hyperglycemia and dyslipidemia is based upon the detection and identification of biomarkers originating from perturbed glucose, amino acid, and lipid metabolism. The emerging “OMICS” technologies, such as metabolomics coupled with statistical and bioinformatics tools, proved to be quite useful to study changes in physiological and biochemical processes at the metabolic level prior to an eventual diagnosis of DM.
    [Show full text]
  • Dibasic Acids for Nylon Manufacture
    - e Report No. 75 DIBASIC ACIDS FOR NYLON MANUFACTURE by YEN-CHEN YEN October 1971 A private report by the PROCESS ECONOMICS PROGRAM STANFORD RESEARCH INSTITUTE MENLO PARK, CALIFORNIA CONTENTS INTRODUCTION, ....................... 1 SUMMARY .......................... 3 General Aspects ...................... 3 Technical Aspects ..................... 7 INDUSTRY STATUS ...................... 15 Applications and Consumption of Sebacic Acid ........ 15 Applications and Consumption of Azelaic Acid ........ 16 Applications of Dodecanedioic and Suberic Acids ...... 16 Applications of Cyclododecatriene and Cyclooctadiene .... 17 Producers ......................... 17 Prices ........................... 18 DIBASIC ACIDS FOR MANUFACTURE OF POLYAMIDES ........ 21 CYCLOOLIGOMERIZATIONOF BUTADIENE ............. 29 Chemistry ......................... 29 Ziegler Catalyst ..................... 30 Nickel Catalyst ..................... 33 Other Catalysts ..................... 34 Co-Cyclooligomerization ................. 34 Mechanism ........................ 35 By-products and Impurities ................ 37 Review of Processes .................... 38 A Process for Manufacture of Cyclododecatriene ....... 54 Process Description ................... 54 Process Discussion .................... 60 Cost Estimates ...................... 60 A Process for Manufacture of Cyclooctadiene ........ 65 Process Description ................... 65 Process Discussion .................... 70 Cost Estimates ...................... 70 A Process for Manufacture of Cyclodecadiene
    [Show full text]
  • Microwave-Assisted Low-Temperature Dehydration Polycondensation of Dicarboxylic Acids and Diols
    Polymer Journal (2011) 43, 1003–1007 & The Society of Polymer Science, Japan (SPSJ) All rights reserved 0032-3896/11 $32.00 www.nature.com/pj RAPID COMMUNICATION Microwave-assisted low-temperature dehydration polycondensation of dicarboxylic acids and diols Polymer Journal (2011) 43, 1003–1007; doi:10.1038/pj.2011.107; published online 26 October 2011 INTRODUCTION time (4100 h). Therefore, we next focused on has been no report concerning a Currently, because of increasing concerns identifying more active catalysts and found that non-thermal effect in microwave-assisted about damage to the environment, the devel- scandium and thulium bis(nonafluorobutane- polycondensation reactions,33,34 although opment of new, eco-friendly (industrially sulfonyl)imide ((Sc(NNf2)3) and (Tm(NNf2)3)) there has been a report that non-thermal relevant) chemical reactions and materials is were more efficient catalysts and allowed us microwaves have a role in the chain polymer- crucial. Aliphatic polyesters have attracted to obtain high-molecular-weight polyesters ization of a lactone.32 Therefore, we studied 4 much interest as environmentally benign, (Mn42.0Â10 ) from adipic acid (AdA) and microwave-assisted syntheses of polyesters at biodegradable polymers.1,2 In general, alipha- 3-methyl-1,5-pentanediol (MPD) at 60 1Cina a relatively low temperature (80 1C) using a tic polyesters are commercially produced by shortperiodoftime(24h)andwithasmaller microwave chamber equipped with a tem- polycondensation of a dicarboxylic acid and a amount of catalyst (0.1 mol%) than had pre- perature control, and the results are reported 1.1–1.5 mol excess of a diol at a temperature viously been possible.26 herein.
    [Show full text]
  • Pharmacokinetics of Sebacic Acid in Rats
    European Review for Medical and Pharmacological Sciences 1999; 3: 119-125 Pharmacokinetics of sebacic acid in rats A.M.R. FAVUZZI, G. MINGRONE, A. BERTUZZI*, S. SALINARI**, A. GANDOLFI*, A.V. GRECO Istituto di Medicina Interna e Geriatria, Catholic University - Rome (Italy) *Istituto di Analisi dei Sistemi ed Informatica, CNR - Rome (Italy) **Dipartimento di Informatica e Sistemistica, Facoltà di Ingegneria, “La Sapienza” University - Rome (Italy) Abstract. – The pharmacokinetics of disodi- enteral nutrition (TPN) as an alternate ener- um sebacate (Sb) was studied in Wistar rats of gy source1-3. The advantage of these diacids both sexes. Sebacate was administered either as over conventional lipid substrates (both long intra-peritoneal (i.p.) bolus (six doses ranging from 10 mg to 320 mg) or as oral bolus (two doses: 80 and medium chain triglycerides) is related to and 160 mg). Plasma and urinary concentrations the immediate availability of their com- of Sb and urinary concentrations of Sb and its pounds. The salts of dicarboxylic acids are products of β-oxidation (suberic and adipic acids) highly water soluble and thus can be directly were measured by an improved method using administered through a peripheral venous gas-liquid chromatography/mass-spectrometry. route. Unlike long chain triglycerides (LCT), A single compartment with two linear elimi- or medium chain triglycerides (MCT), which nation routes was selected after no increase in significance was shown by an additional com- are available under emulsion form for clinical partment and after a saturable mechanism was use, they do not require complex and expen- found to be unsuitable. Both renal and non-re- sive production procedures.
    [Show full text]
  • D 2.1 Background Information and Biorefinery Status, Potential and Sustainability
    Project no.: 241535 – FP7 Project acronym: Star-COLIBRI Project title: Strategic Targets for 2020 – Collaboration Initiative on Biorefineries Instrument: Specific Support Action Thematic Priority: Coordination and support actions D 2.1 Background information and biorefinery status, potential and Sustainability – Task 2.1.2 Market and Consumers; Carbohydrates – Due date of deliverable: March 31, 2010 Start date of project: 01.11.2009 Duration: 24 months Organisation name of lead contractor for this deliverable: UoY Version: 1.0 Project co-funded by the European Commission within the Seventh Framework Programme (2007-2011) Dissemination level PU Public X PP Restricted to other programme participants (including the Commission Services) RE Restricted to a group specified by the consortium (including the Commission Services) CO Confidential, only for members of the consortium (including the Commission Services) Star-COLIBRI - Deliverable 2.1 D 2.1 Background information and biorefinery status, potential and Sustainability – Task 2.1.2 Market and Consumers; Carbohydrates – H.L. Bos, P.F.H. Harmsen & E. Annevelink Wageningen UR – Food & Biobased Research Version 18/03/10 Task 2.1.2 Market and Consumers; Carbohydrates 2 Star-COLIBRI - Deliverable 2.1 Content Management summary ............................................................................................................... 4 1 Introduction ........................................................................................................................ 5 1.1 Task description
    [Show full text]
  • United States Patent Office Patented
    2,826,604 United States Patent Office Patented. Mar. 11, 1958 2 (130-140 C.), the decalyl acetate being recoverable from the reaction mixture by distillation of the neutralized re 2,826,604 action liquid. The recovered product was a straw-colored PREPARATION OF DECAHYDRONAPHTHYL fragrant oil, which was established to be 1-decallyl acetate. ACETATE 5 The position of the acetoxy group was determined by William E. Erner, Wilmington, Del, assignor to Houdry hydrolysis of the ester to the alcohol and subsequent Process Corporation, Wilmington, Del, a corporation conversion to decalone-1 by chromic acid-acetic acid oxi of Delaware dation. - The aceto-oxidation of Decalin can be carried out No Drawing. Application June 2, 1955 10 in the presence of oxidation catalysts of the type em Serial No. 512,853 bodied in the metal salts of the lower fatty acids. Cobalt 2 Claims. (C. 260-488) acetate proved outstanding among the metallic-soap oxi dation catalysts studied. The use of benzoyl peroxide at the start of the process has been found advantageous The present invention relates to the preparation of 1 5 in decreasing the induction period and in giving uni decahydronaphthyl alcohols and the corresponding acetic formly high yields. acid ester and ketone derivatives of Said alcohols. The ratios of Decalin - to acetic anhydride in the oper More particularly the invention is concerned with the ation of the process are not critical, but practical con production of saturated polynuclear carbocyclic com siderations favor the use of at least one-half mol of pounds of the type 20 acetic anhydride per mol of Decalin.
    [Show full text]
  • Chemo-Enzymatic Cascades to Produce Cycloalkenes from Bio-Based Resources
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by edoc ARTICLE https://doi.org/10.1038/s41467-019-13071-y OPEN Chemo-enzymatic cascades to produce cycloalkenes from bio-based resources Shuke Wu 1,3*, Yi Zhou 1, Daniel Gerngross 2, Markus Jeschek 2 & Thomas R. Ward 1* Engineered enzyme cascades offer powerful tools to convert renewable resources into value- added products. Man-made catalysts give access to new-to-nature reactivities that may complement the enzyme’s repertoire. Their mutual incompatibility, however, challenges their 1234567890():,; integration into concurrent chemo-enzymatic cascades. Herein we show that compartmen- talization of complex enzyme cascades within E. coli whole cells enables the simultaneous use of a metathesis catalyst, thus allowing the sustainable one-pot production of cycloalkenes from oleic acid. Cycloheptene is produced from oleic acid via a concurrent enzymatic oxi- dative decarboxylation and ring-closing metathesis. Cyclohexene and cyclopentene are produced from oleic acid via either a six- or eight-step enzyme cascade involving hydration, oxidation, hydrolysis and decarboxylation, followed by ring-closing metathesis. Integration of an upstream hydrolase enables the usage of olive oil as the substrate for the production of cycloalkenes. This work highlights the potential of integrating organometallic catalysis with whole-cell enzyme cascades of high complexity to enable sustainable chemistry. 1 Department of Chemistry, University of Basel, Mattenstrasse 24a, BPR 1096, CH-4058 Basel, Switzerland. 2 Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, CH-4058 Basel, Switzerland. 3Present address: Institute of Biochemistry, University of Greifswald, Felix- Hausdorff-Str.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,406,708 B1 Kairnerud Et Al
    USOO6406708B1 (12) United States Patent (10) Patent No.: US 6,406,708 B1 Kairnerud et al. (45) Date of Patent: Jun. 18, 2002 (54) THERAPEUTIC COMPOSITIONS WO WO 96/11572 A1 4/1996 WO WO 96/21422 A1 7/1996 (75) Inventors: Lars Kärnerud, Tenhult; Stellan WO WO 98/22083 A1 5/1998 Olmeskog, Aneby, both of (SE) OTHER PUBLICATIONS (73) Assignee: Interhealth AB, Huskvarna (SE) Patent Abstracts of Japan, “JP 61-227517 A, Lion Corp., published Oct. 9, 1986”, vol. 11, No. 69 C-407. (*) Notice: Subject to any disclaimer, the term of this Patent Abstracts of Japan “10-087458 A., Lion Corp., pub patent is extended or adjusted under 35 lished Apr. 7, 1998”. U.S.C. 154(b) by 0 days. Patent Abstracts of Japan, “JP 07-138125A,” Shiseido Co. Ltd., published May 30, 1995, vol. 95, No. 5. (21) Appl. No.: 09/700,215 Hoffmann SL et al., “Safety, Immunogenicity, And Efficacy (22) PCT Filed: May 12, 1999 Of A Malaria Sporozoite Vaccine Administered With Mono phosphoryl Lipid A, Cell Wall Skeleton Of Mycobacteria, (86) PCT No.: PCT/SE99/00819 And Squalane AS Adjuvent” Am J Trop Med Hyg, 51(5), pp. S371 (c)(1), 603–612, Nov. 1994. Abstract. (2), (4) Date: Nov. 13, 2000 Allison AC, “Adjuvants and Immune Enhancement' Int. J. Technol. Assess Health Care, 10(1), pp., 107-120, Winter (87) PCT Pub. No.: WO99/58104 1994. Abstract. Stone HD et al., “Efficacy of Experimental Newcastle Dis PCT Pub. Date: Nov. 18, 1999 ease Water-In-Oil Oil-Emulsion Vaccines Formulated from (30) Foreign Application Priority Data Squalane and Squalane.
    [Show full text]
  • Effect of Oral Sebacic Acid on Postprandial Glycemia, Insulinemia, and Glucose Rate of Appearance in Type 2 Diabetes
    Clinical Care/Education/Nutrition/Psychosocial Research ORIGINAL ARTICLE Effect of Oral Sebacic Acid on Postprandial Glycemia, Insulinemia, and Glucose Rate of Appearance in Type 2 Diabetes 1 1 AMERIGO IACONELLI, MD ANGELA FAVUZZI, MD beneficial in terms of reduction of circu- 2 3 AMALIA GASTALDELLI, PHD CHRISTOPHE BINNERT, PHD lating levels of glucose, insulin, and free 1 3 CHIARA CHIELLINI, PHD KATHERINE MACE´, PHD 1 1 fatty acids in type 2 diabetes. Thus, the DONATELLA GNIULI, MD GELTRUDE MINGRONE, MD, PHD availability of snacks poor in fat and that do not induce hyperglycemia and/or overstimulate insulin secretion would be OBJECTIVE — Dicarboxylic acids are natural products with the potential of being an alter- a good tool in the diet of insulin-resistant, nate dietary source of energy. We aimed to evaluate the effect of sebacic acid (a 10-carbon type 2 diabetic subjects. dicarboxylic acid; C10) ingestion on postprandial glycemia and glucose rate of appearance (Ra) in healthy and type 2 diabetic subjects. Furthermore, the effect of C10 on insulin-mediated Dicarboxylic acids are naturally oc- glucose uptake and on GLUT4 expression was assessed in L6 muscle cells in vitro. curring substances produced by both higher plants and animals via ␻-oxidation RESEARCH DESIGN AND METHODS — Subjects ingested a mixed meal (50% car- of fatty acids (6,7). In plants, long-chain bohydrates, 15% proteins, and 35% lipids) containing 0 g (control) or 10 g C10 in addition to dicarboxylic acids are components of nat- the meal or 23 g C10 as a substitute of fats. ural protective polymers, cutin and RESULTS — In type 2 diabetic subjects, the incremental glucose area under the curve (AUC) suberin, which support biopolyesters in- decreased by 42% (P Ͻ 0.05) and 70% (P Ͻ 0.05) in the 10 g C10 and 23 g C10 groups, volved in waterproofing the leaves and respectively.
    [Show full text]
  • Dissociation Constants of Organic Acids and Bases
    DISSOCIATION CONSTANTS OF ORGANIC ACIDS AND BASES This table lists the dissociation (ionization) constants of over pKa + pKb = pKwater = 14.00 (at 25°C) 1070 organic acids, bases, and amphoteric compounds. All data apply to dilute aqueous solutions and are presented as values of Compounds are listed by molecular formula in Hill order. pKa, which is defined as the negative of the logarithm of the equi- librium constant K for the reaction a References HA H+ + A- 1. Perrin, D. D., Dissociation Constants of Organic Bases in Aqueous i.e., Solution, Butterworths, London, 1965; Supplement, 1972. 2. Serjeant, E. P., and Dempsey, B., Ionization Constants of Organic Acids + - Ka = [H ][A ]/[HA] in Aqueous Solution, Pergamon, Oxford, 1979. 3. Albert, A., “Ionization Constants of Heterocyclic Substances”, in where [H+], etc. represent the concentrations of the respective Katritzky, A. R., Ed., Physical Methods in Heterocyclic Chemistry, - species in mol/L. It follows that pKa = pH + log[HA] – log[A ], so Academic Press, New York, 1963. 4. Sober, H.A., Ed., CRC Handbook of Biochemistry, CRC Press, Boca that a solution with 50% dissociation has pH equal to the pKa of the acid. Raton, FL, 1968. 5. Perrin, D. D., Dempsey, B., and Serjeant, E. P., pK Prediction for Data for bases are presented as pK values for the conjugate acid, a a Organic Acids and Bases, Chapman and Hall, London, 1981. i.e., for the reaction 6. Albert, A., and Serjeant, E. P., The Determination of Ionization + + Constants, Third Edition, Chapman and Hall, London, 1984. BH H + B 7. Budavari, S., Ed., The Merck Index, Twelth Edition, Merck & Co., Whitehouse Station, NJ, 1996.
    [Show full text]
  • Structure-Properties Relationship of Fatty Acid-Based Thermoplastics As Synthetic Polymer Mimics Lise Maisonneuve, Thomas Lebarbé, Etienne Grau, Henri Cramail
    Structure-properties relationship of fatty acid-based thermoplastics as synthetic polymer mimics Lise Maisonneuve, Thomas Lebarbé, Etienne Grau, Henri Cramail To cite this version: Lise Maisonneuve, Thomas Lebarbé, Etienne Grau, Henri Cramail. Structure-properties relationship of fatty acid-based thermoplastics as synthetic polymer mimics. Polymer Chemistry, Royal Society of Chemistry - RSC, 2013, 4 (22), pp.5472-5517. 10.1039/c3py00791j. hal-00915225 HAL Id: hal-00915225 https://hal.archives-ouvertes.fr/hal-00915225 Submitted on 22 Nov 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Structure–properties relationship of fatty acid-based thermoplastics as synthetic polymer mimics Lise Maisonneuve, Thomas Lebarbé, Etienne Grau and Henri Cramail* Abstract Nowadays the use of vegetable oils as polymer precursors is the subject of growing interest in the academic and industrial communities. Many synthetic pathways can be pursued from natural vegetable oils to yield different functionalized derivatives – also called synthons – and polymers, such as polyesters, polyurethanes, polyamides, etc. Herein, we widely overview recent progress in the preparation of vegetable oil-based thermoplastic polymers and, more precisely, thermoplastic polyesters and polyurethanes. Extra focus is also placed on the synthesis sustainability of these polymeric materials via atom efficient techniques, “green” catalyses and processes.
    [Show full text]
  • PINK BOOK 3 Sebacic Acid/Dicarboxylic Acids CIR EXPERT PANEL MEETING AUGUST 30-31, 2010
    PINK BOOK 3 Sebacic Acid/Dicarboxylic Acids CIR EXPERT PANEL MEETING AUGUST 30-31, 2010 Memorandum To: CIR Expert Panel Members and Liaisons From: Monice M. Fiume MMF Senior Scientific Analyst/Writer Bart A. Heldreth, Ph.D. BAH Chemist Date: July 30, 2010 Subject: Draft Report on Dicarboxylic Acids (previously called Diisopropyl Sebacate) The draft report on dicarboxylic acids was last reviewed in December 2009, under the title Diisopropyl Sebacate. At that time, the report was tabled for reorganization. Also at that time, it was determined that oxalic acid would not be part of the safety assessment. The entire report has been reorganized and rewritten. It will be obvious that the Chemistry section is now prepared in a way that allows you to view the dicarboxylic acids in order of increasing chain length. Also included are charts demonstrating the relationship between molecular weight and the log octanol – water partitioning coefficient. Additionally, the report, from the General Biology section on, is now divided into two sections, as was suggested by the Panel in December. The first section addresses dicarboxylic acids and their salts, while the second part addresses esters of dicarboxylic acids. These two subsets of ingredients have different functions in cosmetics, and this will allow the Panel to view the data on each subset separately. In addition to the reorganization, the report has change greatly in the extent of data included. A complete new search of the literature has been performed, and a substantial amount of new data has been added. A great deal of the information included in this report has come from summary documents, such as HPV robust summaries, that cite unpublished sources.
    [Show full text]